PHG - Philips ordered by FDA to notify patients about CPAP/BiPAP machine recall

The U.S. FDA has ordered Philips (NYSE:PHG) to notify users of its Philips Respironics CPAP, BiPAP and ventilator machines of a recall from June 2021 of certain of the products over foam used in the product. The agency called notification efforts form the company so far "inadequate." Millions of the sleep apnea machines were recalled last year amid concerns that the foam could break apart and be breathed in by the user. Philips said that it has so far shipped more than 650K replacement devices in the U.S., and is eyeing completion of the repair and replacement program in Q4. The company added it has been using its app, DreamMapper, to send notifications to patients. Read why Seeking Alpha contributor Stephen Simpson calls Philips (PHG) a buy.

For further details see:

Philips ordered by FDA to notify patients about CPAP/BiPAP machine recall